Salazar, J., Altés, A., del Río, E., Estella, J., Rives, S., Tasso, M., . . . Badell, I. (2012). Methotrexate consolidation treatment according to pharmacogenetics of MTHFR ameliorates event-free survival in childhood acute lymphoblastic leukaemia. Pharmacogenomics Journal, 12(5), 379. https://doi.org/10.1038/tpj.2011.25
Chicago Style (17th ed.) CitationSalazar, J., et al. "Methotrexate Consolidation Treatment According to Pharmacogenetics of MTHFR Ameliorates Event-free Survival in Childhood Acute Lymphoblastic Leukaemia." Pharmacogenomics Journal 12, no. 5 (2012): 379. https://doi.org/10.1038/tpj.2011.25.
MLA (9th ed.) CitationSalazar, J., et al. "Methotrexate Consolidation Treatment According to Pharmacogenetics of MTHFR Ameliorates Event-free Survival in Childhood Acute Lymphoblastic Leukaemia." Pharmacogenomics Journal, vol. 12, no. 5, 2012, p. 379, https://doi.org/10.1038/tpj.2011.25.